GlassScriptPhysician profile
Stephen M Reed
NPI 1386608727
$4,577.04
in general payments reported to CMS, 2019-2025
23 companies · $2,646 in 2025
The $2,646 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $280 · 2021: $225 · 2022: $45.27 · 2023: $449 · 2024: $439 · 2025: $2,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,036 · Travel and Lodging: $1,451 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,035.84 |
| Travel and Lodging | $1,451.47 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,163.30 | 2019-2025 | Oxford, Rosa, Mymobility Platform |
| Pacira Pharmaceuticals Incorporated | $282.78 | 2019-2025 | Iovera, Exparel, Zilretta |
| Amgen INC. | $192.04 | 2019-2025 | Evenity |
| Pacira Therapeutics, INC. | $114.49 | 2019-2020 | |
| Smith+Nephew, INC. | $104.91 | 2019-2023 | Trigen Intertan, Evos |
| Exactech, INC. | $99.15 | 2020 | |
| Stryker Corporation | $98.81 | 2019-2020 | |
| Radius Health, INC. | $83.92 | 2019-2021 | |
| Heraeus Medical, LLC. | $72.31 | 2023-2025 | Palacos |
| Curonix LLC | $66.45 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ermi LLC | $44.07 | 2019 | |
| Ferring Pharmaceuticals INC. | $43.40 | 2019-2020 | |
| Kerecis Limited | $31.31 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $24.72 | 2024 | |
| Davol INC. | $22.75 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.67 | 2024 | |
| Heron Therapeutics, INC. | $19.72 | 2024 | Zynrelef |
| Globus Medical, INC. | $16.85 | 2021 | |
| Si-Bone, INC. | $16.15 | 2019 | |
| Boston Scientific Corporation | $15.63 | 2019 | |
| Ossur Americas, INC. | $15.16 | 2024 | Miami J |
| Ethicon US, LLC | $14.55 | 2024 | Megadyne, Vistaseal |
| Joint Active Systems, INC. | $13.90 | 2025 | Joint Active Systems, INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.